ArticlePloS one2025
Global burden of cardiovascular diseases attributable to diet low in seafood omega-3 fatty acids from 1990~2021 and forecasting the future trends: A population-based study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Efficacy of omega-3 fatty acids as a functional food: a multifaceted approach to health reinforcement.Journal of the science of food and agriculture · 2026Review
- Association of Fish Consumption with the Omega-3 Index and Vitamin D Status among Adolescent Females in the Southwest Coastal Zone of Bangladesh.The Journal of nutrition · 2026Article
- An analysis of the burden of colorectal cancer caused by high body mass index in 204 countries and regions worldwide from 1990 to 2023.Journal of global health · 2026Article
- Article
- Global burden of mental disorders in 204 countries and territories results from the Global Burden of Disease Study 2021.World journal of psychiatry · 2025Article
- Association of biological aging and the prevalence of nonalcoholic fatty liver disease: a population-based study.BMC gastroenterology · 2025Article
- Rising colorectal cancer burden attributable to high body mass index in China from 1990 to 2021: a comprehensive analysis using the global burden of disease study.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis research investigates the worldwide influence of cardiovascular diseases (CVD) associated with low intake of seafood omega-3 fatty acids, based on data from the 2021 Global Burden of Disease Study.
methodThe study evaluated the effects of insufficient seafood omega-3 fatty acid consumption on CVD at international, regional, and country levels. It analyzed variations across different demographics, including age and gender, and explored the relationship between disease burden and the Socio-Demographic Index (SDI). Additionally, it utilized an ARIMA model to predict the incidence of CVD connected to this dietary deficiency until 2050.
resultIn 2021, diets deficient in seafood omega-3 fatty acids contributed to roughly 737.88 thousand deaths and 17.87 million disability-adjusted life years (DALYs) from CVD, with a noted decrease in this health impact over the period studied. The most substantial effects were seen in the elderly, particularly those aged 75 and above, with males experiencing a higher disease impact. Future forecasts suggest probable declines in disease rates across all SDI areas. However, nations in North Africa and the Middle East are projected to encounter growing difficulties related to CVD stemming from low seafood omega-3 intake by 2030 and 2050.
conclusionThese results highlight the critical need for preventive strategies against CVD and stress the significance of dietary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.